AI assistant
Sending…
STEPAN CO — Director's Dealing 2020
Dec 11, 2020
32175_dirs_2020-12-11_d0ca3992-96bb-4e56-808a-0a29a495b93e.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: STEPAN CO (SCL)
CIK: 0000094049
Period of Report: 2020-12-09
Reporting Person: Catlett Janet Anne (VP, CHRO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2020-12-09 | Common Stock | M | 1256 | $81.63 | Acquired | 2274.783 | Direct |
| 2020-12-09 | Common Stock | D | 867 | $118.25 | Disposed | 1825.783 | Direct |
| 2020-12-09 | Common Stock | F | 165 | $118.25 | Disposed | 1660.783 | Direct |
| 2020-12-09 | Common Stock | M | 418 | $81.63 | Acquired | 2692.783 | Direct |
| 2020-12-09 | Common Stock | S | 418 | $118.247 | Disposed | 1242.783 | Direct |
| 2020-12-09 | Common Stock | S | 224 | $118.264 | Disposed | 1018.783 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2020-12-09 | Stock Appreciation Right | $81.63 | M | 1256 | Disposed | 2028-07-22 | Common Stock (1256) | Direct |
| 2020-12-09 | Stock Option (Right to Buy) | $81.63 | M | 418 | Disposed | 2028-07-22 | Common Stock (418) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 117.545 | Indirect |
Footnotes
F1: The Stock Appreciation Rights ("SARS") were settled in shares of common stock as per the terms of the award.
F2: Deemed disposition of underlying common stock to the issuer in an amount equal to the conversion price of the SARs.
F3: Withholding of shares to satisfy tax liability on exercise of SARs.
More from STEPAN CO
Regulatory Filings
2026
May 29
Interim / Quarterly Report
2026
May 6
Regulatory Filings
2026
Apr 30
Major Shareholding Notification
2026
Apr 29
Regulatory Filings
2026
Apr 28
Major Shareholding Notification
2026
Mar 27
Annual Report
2026
Mar 25
Proxy Solicitation & Information Statement
2026
Mar 25
Annual Report
2026
Feb 26
Regulatory Filings
2026
Feb 23